24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Explore the success rates, benefits, risks, and candidacy for Deep Brain Stimulation (DBS) surgery as a treatment option for Parkinson's disease when medications are no longer sufficient.

Parkinson's disease is a progressive neurological disorder that primarily affects movement. It is characterized by symptoms such as tremors, rigidity, slowness of movement, and postural instability. While medications that boost dopamine levels can help manage these symptoms, their effectiveness often diminishes over time. For individuals whose symptoms are no longer adequately controlled by medication, Deep Brain Stimulation (DBS) surgery presents a significant treatment option. This article delves into the success rates of DBS for Parkinson's disease, its benefits, potential risks, and who might be a suitable candidate.
Deep Brain Stimulation (DBS) is a surgical procedure that involves implanting a small, battery-operated device, known as a neurostimulator, into the brain. This device sends electrical impulses to specific areas of the brain that are affected by Parkinson's disease. These electrical impulses help to regulate abnormal brain activity, thereby alleviating motor symptoms such as tremors, stiffness, and slowness of movement. The neurostimulator is typically implanted in the chest or abdomen, with wires running under the skin to the brain.
The success of DBS for Parkinson's disease is evaluated based on several factors, including its effectiveness in managing motor symptoms, improving quality of life, and potentially influencing the progression of the disease. Research indicates a generally positive outlook:
DBS is typically considered for individuals who have been diagnosed with Parkinson's disease for approximately 4 years and whose symptoms are no longer adequately managed by medication. However, research is also exploring the benefits of earlier intervention. Some studies suggest that performing DBS earlier, even between 6 months and 4 years after diagnosis, can lead to significant symptom control and reduced medication needs.
Despite its benefits, DBS is a surgical procedure and carries potential risks and downsides:
An ideal candidate for DBS typically:
If you or a loved one has Parkinson's disease and are experiencing:
It is crucial to discuss the potential benefits and risks of Deep Brain Stimulation with your neurologist or movement disorder specialist. They can assess your individual situation and determine if DBS is a viable treatment option for you.
No, DBS does not cure Parkinson's disease. It is a treatment that helps manage the motor symptoms of the disease, improving quality of life for many individuals.
DBS is intended to provide long-term symptom management. The effects can last for many years, although the stimulation settings may need to be adjusted over time as the disease progresses.
Yes, the neurostimulator can be turned off if necessary, for example, if there are significant side effects or if the patient needs to undergo certain medical imaging procedures like MRI (though MRI-compatible systems are available).
The implantation surgery is performed under anesthesia, so you will not feel pain during the procedure. After surgery, some discomfort is expected, which can be managed with pain medication. Once the device is active, most patients do not feel the electrical stimulation itself.
DBS is particularly effective at reducing tremors, often leading to significant improvement in this symptom for many patients.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026